Agilon Health Announces 1-for-25 Reverse Stock Split

Agilon Health ( (AGL) ) has provided an update.

On March 17, 2026, Agilon Health stockholders approved an amendment to its certificate of incorporation authorizing a reverse stock split at a ratio between 1-for-5 and 1-for-25, and the board subsequently set the split at 1-for-25. The move follows a special shareholder meeting where investors also backed the option to adjourn the session if additional proxy solicitation had been needed.

In a March 18, 2026 announcement, the company said the 1-for-25 reverse split is scheduled to take effect at 5:00 p.m. Eastern on March 30, 2026, with split-adjusted trading on the NYSE to begin on March 31 under the existing AGL ticker. The consolidation, which will leave roughly 16.6 million shares outstanding and pay cash in lieu of fractions, is aimed at lifting the share price above the NYSE’s $1.00 minimum, preserving the listing, and potentially broadening the stock’s appeal and liquidity for investors.

The most recent analyst rating on (AGL) stock is a Hold with a $0.68 price target. To see the full list of analyst forecasts on Agilon Health stock, see the AGL Stock Forecast page.

Spark’s Take on AGL Stock

According to Spark, TipRanks’ AI Analyst, AGL is a Neutral.

The score is held down primarily by weak financial performance (ongoing losses, negative EBITDA, and persistent cash burn) and a clearly bearish technical setup (price below all key moving averages with negative MACD). The latest earnings call improves the outlook with quantified 2026 breakeven-EBITDA guidance and operational levers, but elevated medical cost trends, membership contraction, and policy uncertainty keep risk high; valuation is difficult to assess given the negative P/E.

To see Spark’s full report on AGL stock, click here.

More about Agilon Health

Agilon Health, Inc. is a healthcare services company that partners with physician groups and health systems to help them transition senior patient care to a value-based Total Care Model. Through a purpose-built platform, capital support, and a peer network of roughly 2,300 primary care physicians across about 30 communities, the company focuses on improving outcomes for Medicare Advantage and other senior-focused populations.

Agilon provides technology, people, and processes that enable independent physician groups to manage the total health of vulnerable patients while maintaining their autonomy. By aligning incentives around care quality rather than service volume, the company aims to create healthier communities and support sustainable, long-term growth for leading physician organizations and health systems nationwide.

Average Trading Volume: 6,680,405

Technical Sentiment Signal: Sell

Current Market Cap: $254.7M

See more insights into AGL stock on TipRanks’ Stock Analysis page.